Thrombosis in Cancer Patients (TCP) Project
Description
This compendium contains SOPs contributed by the Thrombosis in Cancer Patients (TCP) study. The overall objective of the TCP study is to guide the standardization of methods and approaches used for measuring biomarkers of thrombosis. In particular, the study was designed to identify the impact of three pre-analytic variables (delay to centrifugation, freeze/thaw cycles, and delay to testing) on analysis of twelve plasma biomarkers in cancer patients and non-cancer control donors using standardized methodologies. The SOPs in this compendium are a product of the Center for Strategic Scientific Initiatives (CSSI) of the National Institutes of Health (NIH) (https://www.cancer.gov/about-nci/organization/cssi/research/past-programs#thrombosis-in-cancer-standardization-of-biomarker-measurements).
Sources
- TCP Project
Standard Operating Procedures (16)
| Title | Version | Source |
|---|---|---|
| Blood Sample Collection SOP | TCP Project | |
| Factor Assay – VIII, IX, XI, XII | TCP Project | |
| D-Dimer HS | TCP Project | |
| Prothrombin Fragment 1+2 ELISA | TCP Project | |
| Soluble P Selectin ELISA | TCP Project | |
| Plasma DNA Assay | TCP Project | |
| Nucleosome ELISA | TCP Project | |
| Myeloperoxidase assay | TCP Project | |
| PAI-1 ELISA | TCP Project | |
| Plasmin-Antiplasmin ELISA | TCP Project | |
| Blood Sample Processing, Storage and Shipping | TCP Project | |
| Soluble Thrombomodulin | TCP Project | |
| IL-6 ELISA | TCP Project | |
| Soluble Tissue Factor | TCP Project | |
| IL-6 ELISA (New Kit) | TCP Project | |
| Soluble P Selectin ELISA (DPSE100) | TCP Project |